Cargando…
Skin Testing to Identify Safe Drugs for Patients with Rocuronium-Induced Anaphylaxis
Among patients who develop anaphylaxis during anesthesia, anaphylaxis caused by a neuromuscular blocking agent has the highest incidence. In patients who developed IgE-mediated anaphylaxis, and cross-reactivity among NMBAs is a concern in subsequent anesthetic procedures. We present a patient who de...
Autores principales: | Suzuki, Manzo, Kawase, Hajime, Ogita, Azusa, Bito, Hiroyasu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008275/ https://www.ncbi.nlm.nih.gov/pubmed/32082637 http://dx.doi.org/10.1155/2020/8163620 |
Ejemplares similares
-
Negative Pressure Pulmonary Edema after Reversing Rocuronium-Induced Neuromuscular Blockade by Sugammadex
por: Suzuki, Manzo, et al.
Publicado: (2014) -
Sugammadex and rocuronium-induced anaphylaxis
por: Takazawa, Tomonori, et al.
Publicado: (2015) -
Rocuronium-induced anaphylaxis: a case report
por: Takahashi, Kanako, et al.
Publicado: (2019) -
Rocuronium bromide induced anaphylaxis in a child -A case report-
por: Jang, Young Ho, et al.
Publicado: (2010) -
Anaphylaxis induced by sugammadex and sugammadex-rocuronium complex -a case report-
por: Choi, Shu Chung, et al.
Publicado: (2020)